NASDAQ:AMDA - Amedica Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started Previous Close$0.1888Today's Range$0.17 - $0.189952-Week Range$0.18 - $6.40Volume125,933 shsAverage Volume1.07 million shsMarket Capitalization$2.23 millionP/E RatioN/ADividend YieldN/ABeta-1.24 ProfileAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Amedica Corporation, a biomaterial company, develops, manufactures, and commercializes a range of medical devices based on its silicon nitride technology platform in the United States, Europe, and South America. The company offers silicon nitride implants to surgeons and hospitals for use in cervical and thoracolumbar spine surgery under the Valeo brand. It also provides a line of non-silicon nitride spinal fixation products to address spinal deformity and degenerative conditions. The company markets and sells its products directly; and through a network of independent sales distributors, as well original equipment manufacturer and private label partnerships. Amedica Corporation was founded in 1996 and is headquartered in Salt Lake City, Utah. Receive AMDA News and Ratings via Email Sign-up to receive the latest news and ratings for AMDA and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:AMDA Previous Symbol CUSIPN/A CIK1269026 Webwww.amedica.com Phone801-839-3500Debt Debt-to-Equity RatioN/A Current Ratio1.11 Quick Ratio0.99Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$11.23 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value$1.80 per share Price / BookN/AProfitability EPS (Most Recent Fiscal Year)($3.13) Net Income$-9,320,000.00 Net Margins-139.62% Return on Equity-148.60% Return on Assets-67.83%Miscellaneous EmployeesN/A Outstanding Shares11,870,000Market Cap$2.23 million Next Earnings DateN/A OptionableNot Optionable Amedica (NASDAQ:AMDA) Frequently Asked Questions What is Amedica's stock symbol? Amedica trades on the NASDAQ under the ticker symbol "AMDA." When did Amedica's stock split? How did Amedica's stock split work? Amedica shares reverse split on Friday, November 10th 2017. The 1-12 reverse split was announced on Friday, November 10th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, November 9th 2017. An investor that had 100 shares of Amedica stock prior to the reverse split would have 8 shares after the split. How were Amedica's earnings last quarter? Amedica Co. (NASDAQ:AMDA) announced its quarterly earnings results on Tuesday, November, 21st. The medical equipment provider reported ($0.93) EPS for the quarter, topping analysts' consensus estimates of ($0.94) by $0.01. The medical equipment provider earned $2.96 million during the quarter. Amedica had a negative return on equity of 148.60% and a negative net margin of 139.62%. View Amedica's Earnings History. Has Amedica been receiving favorable news coverage? Media coverage about AMDA stock has trended somewhat negative recently, according to InfoTrie. InfoTrie ranks the sentiment of news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Amedica earned a daily sentiment score of -1.6 on InfoTrie's scale. They also gave media headlines about the medical equipment provider a news buzz of 8.0 out of 10, meaning that recent news coverage is very likely to have an effect on the stock's share price in the next few days. Who are some of Amedica's key competitors? Some companies that are related to Amedica include United American Healthcare (UAHC), Neurometrix (NURO), Cytori Therapeutics (CYTX), Encision (ECIA), CELLECT BIOTECH/S (APOP), Regenicin (RGIN), Calmare Therapeutics (CTTC), Presbia (LENS), Delcath Systems (DCTH), AdvanSource Biomaterials Corpration (ASNB), Cytocore (MDIT), TearLab (TEAR), Quantrx Biomedical (QTXB), Hypertension Diagnostics (HDII) and Lombard Medical (EVARF). What other stocks do shareholders of Amedica own? Based on aggregate information from My MarketBeat watchlists, some companies that other Amedica investors own include Intrepid Potash (IPI), ParkerVision (PRKR), Pernix Therapeutics (PTX), Anavex Life Sciences (AVXL), Net Element (NETE), Synergy Pharmaceuticals (SGYP), General Electric (GE), SLS International (SLS), Great Basin Scientific (GBSN) and Sophiris Bio (SPHS). Who are Amedica's key executives? Amedica's management team includes the folowing people: Dr. B. Sonny Bal, Chairman, CEO, Pres & Principal Financial Officer (Age 56)Mr. Bryan J. McEntire, Chief Technology Officer (Age 66)Mr. David O'brien, GM & VP Operations How do I buy shares of Amedica? Shares of AMDA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. How big of a company is Amedica? Amedica has a market capitalization of $0.00 and generates $11.23 million in revenue each year. The medical equipment provider earns $-9,320,000.00 in net income (profit) each year or ($3.13) on an earnings per share basis. What is Amedica's official website? The official website for Amedica is http://www.amedica.com. How can I contact Amedica? Amedica's mailing address is 1885 WEST 2100 SOUTH, SALT LAKE CITY UT, 84119. The medical equipment provider can be reached via phone at 801-839-3500 or via email at [email protected] MarketBeat Community Rating for Amedica (NASDAQ AMDA)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 259 (Vote Outperform)Underperform Votes: 271 (Vote Underperform)Total Votes: 530MarketBeat's community ratings are surveys of what our community members think about Amedica and other stocks. Vote "Outperform" if you believe AMDA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AMDA will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/20/2019 by MarketBeat.com StaffFeatured Article: The basics of gap trading strategies Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.